Osteoprotective Roles of Green Tea Catechins.
Hsuan-Ti HuangTsung-Lin ChengSung-Yen LinCheng-Jung HoJoanna Y ChyuRong-Sen YangChung-Hwan ChenChwan-Li ShenPublished in: Antioxidants (Basel, Switzerland) (2020)
Osteoporosis is the second most common disease only secondary to cardiovascular disease, with the risk of fracture increasing with age. Osteoporosis is caused by an imbalance between osteoblastogenesis and osteoclastogenesis processes. Osteoclastogenesis may be enhanced, osteoblastogenesis may be reduced, or both may be evident. Inflammation and high reactive oxygen enhance osteoclastogenesis while reducing osteoblastogenesis by inducing osteoblast apoptosis and suppressing osteoblastic proliferation and differentiation. Catechins, the main polyphenols found in green tea with potent anti-oxidant and anti-inflammatory properties, can counteract the deleterious effects of the imbalance of osteoblastogenesis and osteoclastogenesis caused by osteoporosis. Green tea catechins can attenuate osteoclastogenesis by enhancing apoptosis of osteoclasts, hampering osteoclastogenesis, and prohibiting bone resorption in vitro. Catechin effects can be directly exerted on pre-osteoclasts/osteoclasts or indirectly exerted via the modulation of mesenchymal stem cells (MSCs)/stromal cell regulation of pre-osteoclasts through activation of the nuclear factor kB (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system. Catechins also can enhance osteoblastogenesis by enhancing osteogenic differentiation of MSCs and increasing osteoblastic survival, proliferation, differentiation, and mineralization. The in vitro effects of catechins on osteogenesis have been confirmed in several animal models, as well as in epidemiological observational studies on human subjects. Even though randomized control trials have not shown that catechins provide anti-fracture efficacy, safety data in the trials are promising. A large-scale, placebo-controlled, long-term randomized trial with a tea regimen intervention of optimal duration is required to determine anti-fracture efficacy.
Keyphrases
- bone loss
- mesenchymal stem cells
- nuclear factor
- oxidative stress
- anti inflammatory
- postmenopausal women
- placebo controlled
- cardiovascular disease
- bone mineral density
- double blind
- signaling pathway
- umbilical cord
- endothelial cells
- toll like receptor
- bone marrow
- endoplasmic reticulum stress
- cell therapy
- cell death
- type diabetes
- lps induced
- open label
- cell cycle arrest
- hip fracture
- clinical trial
- immune response
- phase ii
- vascular smooth muscle cells
- big data
- metabolic syndrome
- inflammatory response
- machine learning
- study protocol
- radiation therapy
- cell proliferation
- deep learning
- electronic health record
- rectal cancer
- angiotensin ii
- cardiovascular risk factors